{
    "Trade/Device Name(s)": [
        "OralTox Oral Fluid Drug Test"
    ],
    "Submitter Information": "Premier Biotech Inc",
    "510(k) Number": "K171403",
    "Predicate Device Reference 510(k) Number(s)": [
        "K103227"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJC",
        "DIO",
        "DJG",
        "LCM",
        "LDJ",
        "DKZ"
    ],
    "Summary Letter Date": "January 4, 2018",
    "Summary Letter Received Date": "January 5, 2018",
    "Submission Date": "February 1, 2018",
    "Regulation Number(s)": [
        "21CFR862.3610",
        "21CFR862.3250",
        "21CFR862.3650",
        "21CFR862.3100",
        "21CFR862.3870"
    ],
    "Regulation Name(s)": [
        "Methamphetamine Test System",
        "Cocaine Test System",
        "Opiate Test System",
        "Amphetamine Test System",
        "Cannabinoids Test System",
        "Enzyme Immunoassay Phencyclidine Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Cocaine",
        "Marijuana (THC)",
        "Methamphetamine",
        "Opiates",
        "Phencyclidine"
    ],
    "Specimen Type(s)": [
        "Oral fluid"
    ],
    "Specimen Container(s)": [
        "Device-integrated collection unit (OralTox device)"
    ],
    "Instrument(s)/Platform(s)": [
        "OralTox device"
    ],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunochromatographic assay",
        "Competitive binding immunoassay"
    ],
    "Methodologies": [
        "Immunochromatographic lateral flow",
        "Competitive binding"
    ],
    "Submission Type(s)": [
        "Assay",
        "Specimen collection device"
    ],
    "Document Summary": "FDA 510(k) summary for OralTox Oral Fluid Drug Test, a lateral flow immunochromatographic assay for qualitative detection of six drugs of abuse in oral fluid.",
    "Indications for Use Summary": "Qualitative and simultaneous detection of amphetamine, cocaine, marijuana (THC), methamphetamine, opiates, and phencyclidine and their metabolites in human oral fluid; for preliminary screening with confirmatory testing required.",
    "fda_folder": "Toxicology"
}